Cargando…
Immature Midbrain Dopaminergic Neurons Derived from Floor‐Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease
Recent reports have indicated human embryonic stem cells‐derived midbrain dopamine (mDA) neurons as proper cell resources for use in Parkinson's disease (PD) therapy. Nevertheless, no detailed and systematic study has been conducted to identify which differentiation stages of mDA cells are most...
Autores principales: | Qiu, Lifeng, Liao, Mei‐Chih, Chen, Allen K., Wei, Shunhui, Xie, Shaoping, Reuveny, Shaul, Zhou, Zhi Dong, Hunziker, Walter, Tan, Eng King, Oh, Steve K. W., Zeng, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689771/ https://www.ncbi.nlm.nih.gov/pubmed/28650520 http://dx.doi.org/10.1002/sctm.16-0470 |
Ejemplares similares
-
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
por: Fedele, Stefania, et al.
Publicado: (2017) -
The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson’s disease
por: Qarin, Shamma, et al.
Publicado: (2021) -
Targeting transcriptional regulators to regenerate midbrain dopaminergic axons in Parkinson's disease
por: Hegarty, Shane V., et al.
Publicado: (2017) -
Acquisition of the Midbrain Dopaminergic Neuronal Identity
por: Mesman, Simone, et al.
Publicado: (2020) -
Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside
por: Wang, Mengmeng, et al.
Publicado: (2020)